IN HB1116 | 2020 | Regular Session

Status

Spectrum: Bipartisan Bill
Status: Introduced on January 8 2020 - 25% progression, died in committee
Action: 2020-01-23 - Representatives Clere and Davisson added as coauthors
Pending: House Insurance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Drug information reporting. Requires prescription drug manufacturers, health insurance issuers, pharmacy benefits managers, and wholesale drug distributors (reporting entities) to report certain information to the department of insurance (department), including increases in the wholesale acquisition cost of brand name drugs and generic drugs, the introduction into the United States of a new drug, and spending on prescription drugs before enrollee cost sharing for each of the top 25 prescription drugs and drug groups. Requires reporting entities to pay an annual assessment to support the operational costs incurred by the department in connection with the reporting. Requires a reporting entity to certify under the penalty of perjury that a required report is accurate. Authorizes the insurance commissioner to impose a civil penalty on a reporting entity that fails to comply with a reporting requirement. Requires the department to annually prepare and make available on its web site a report on emerging trends in prescription drug prices. Requires the department to keep confidential and protect from public disclosure all information submitted by reporting entities.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug information reporting.

Sponsors


History

DateChamberAction
2020-01-23HouseRepresentatives Clere and Davisson added as coauthors
2020-01-13HouseRepresentative Austin added as coauthor
2020-01-08HouseFirst reading: referred to Committee on Insurance
2020-01-08HouseAuthored by Representative Shackleford

Indiana State Sources


Bill Comments

feedback